Trade Summary

4 days ago, McNeill Jonathan, serving as President and COO at CRESCENT BIOPHARMA, INC. (CBIO), sold 20,549 shares at $17.99 per share, for a total transaction value of $369,676.51. Following this transaction, McNeill Jonathan now holds 139,158 shares of CBIO.

This sale represents a 12.87% decrease in McNeill Jonathan's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, June 23, 2026 at 4:02 PM ET, 1 day after the trade was made.

CRESCENT BIOPHARMA, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.